Caris Life Sciences Inc (CAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 821,147 | 797,799 | 754,739 | 720,444 | N/A |
| Marketable Securities | 2,315 | 2,295 | 2,272 | 2,249 | N/A |
| Receivables | 90,517 | 112,140 | 26,697 | 50,889 | N/A |
| Inventories | 76,289 | 63,625 | 49,303 | 40,613 | N/A |
| TOTAL | $1,014,180 | $997,800 | $854,245 | $833,319 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 82,669 | 63,170 | 63,997 | 61,315 | N/A |
| Intangibles | 19,344 | 19,344 | 19,344 | 19,344 | 0 |
| Other Non-Current Assets | 46,195 | 45,349 | 46,985 | 41,080 | 0 |
| TOTAL | $148,208 | $127,863 | $130,326 | $121,739 | $N/A |
| Total Assets | $1,162,388 | $1,125,663 | $984,571 | $955,058 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 173 | 169 | 164 | 95 | N/A |
| Accounts payable and accrued liabilities | 69,802 | 39,206 | 28,999 | 28,728 | 0 |
| Accrued Expenses | 73,921 | 87,770 | 56,867 | 61,357 | N/A |
| TOTAL | $143,896 | $127,145 | $86,030 | $90,180 | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | 381,402 | 378,823 | 376,296 | 373,611 | N/A |
| Other Non-Current Liabilities | 43,600 | 42,388 | 43,881 | 38,363 | 0 |
| TOTAL | $425,002 | $421,211 | $420,177 | $411,974 | $N/A |
| Total Liabilities | $568,898 | $548,356 | $506,207 | $502,154 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 282,681 | 282,580 | 282,147 | 281,224 | N/A |
| Common Shares | 284 | 283 | 283 | 282 | N/A |
| Retained earnings | -2,549,246 | -2,548,736 | -2,630,693 | -2,655,018 | N/A |
| Other shareholders' equity | 997 | 1,040 | 831 | 752 | 0 |
| TOTAL | $593,490 | $577,307 | $478,364 | $452,904 | $N/A |
| Total Liabilities And Equity | $1,162,388 | $1,125,663 | $984,571 | $955,058 | $0 |